STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZYME
  4. [ARS] Zymeworks Inc. SEC Filing

[ARS] Zymeworks Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - Zymeworks Inc.

ARS Filing - Zymeworks Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Zymeworks Inc. (ZYME)

Acceptance Date: 2025-11-10T16:31:24.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Zymeworks

NASDAQ:ZYME

View ZYME Stock Overview →

ZYME Rankings

#2231 Ranked by Market Cap
N/A Ranked by Dividends

ZYME Latest News

Mar 24, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences
Mar 18, 2026
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
Mar 17, 2026
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
Mar 2, 2026
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
Mar 2, 2026
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

ZYME Latest SEC Filings

Mar 6, 2026
[144] Zymeworks Inc. SEC Filing
Mar 2, 2026
[10-K] Zymeworks Inc. Files Annual Report
Mar 2, 2026
[8-K] Zymeworks Inc. Reports Material Event
Mar 2, 2026
[8-K] Zymeworks Inc. Reports Material Event
Feb 17, 2026
[144] Zymeworks Inc. SEC Filing

ZYME Stock Data

1.83B
69.56M
Biotechnology
Pharmaceutical Preparations
Link
United States
MIDDLETOWN